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Expression of the transient receptor potential
channels TRPV1, TRPA1 and TRPM8 in mouse
trigeminal primary afferent neurons innervating
the dura
Dongyue Huang1, Shuyang Li1, Ajay Dhaka2, Gina M Story1 and Yu-Qing Cao1*

Abstract
Background: Migraine and other headache disorders affect a large percentage of the population and cause
debilitating pain. Activation and sensitization of the trigeminal primary afferent neurons innervating the dura and
cerebral vessels is a crucial step in the “headache circuit”. Many dural afferent neurons respond to algesic and
inflammatory agents. Given the clear role of the transient receptor potential (TRP) family of channels in both
sensing chemical stimulants and mediating inflammatory pain, we investigated the expression of TRP channels in
dural afferent neurons.
Methods: We used two fluorescent tracers to retrogradely label dural afferent neurons in adult mice and quantified
the abundance of peptidergic and non-peptidergic neuron populations using calcitonin gene-related peptide
immunoreactivity (CGRP-ir) and isolectin B4 (IB4) binding as markers, respectively. Using immunohistochemistry, we
compared the expression of TRPV1 and TRPA1 channels in dural afferent neurons with the expression in total
trigeminal ganglion (TG) neurons. To examine the distribution of TRPM8 channels, we labeled dural afferent
neurons in mice expressing farnesylated enhanced green fluorescent protein (EGFPf) from a TRPM8 locus. We used
nearest-neighbor measurement to predict the spatial association between dural afferent neurons and neurons
expressing TRPA1 or TRPM8 channels in the TG.
Results and conclusions: We report that the size of dural afferent neurons is significantly larger than that of total
TG neurons and facial skin afferents. Approximately 40% of dural afferent neurons exhibit IB4 binding. Surprisingly,
the percentage of dural afferent neurons containing CGRP-ir is significantly lower than those of total TG neurons
and facial skin afferents. Both TRPV1 and TRPA1 channels are expressed in dural afferent neurons. Furthermore,
nearest-neighbor measurement indicates that TRPA1-expressing neurons are clustered around a subset of dural
afferent neurons. Interestingly, TRPM8-expressing neurons are virtually absent in the dural afferent population, nor
do these neurons cluster around dural afferent neurons. Taken together, our results suggest that TRPV1 and TRPA1
but not TRPM8 channels likely contribute to the excitation of dural afferent neurons and the subsequent activation
of the headache circuit. These results provide an anatomical basis for understanding further the functional
significance of TRP channels in headache pathophysiology.
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Background
Migraine and other primary headache disorders affect a
large proportion of the general population and often
cause debilitating pain. A crucial step in the pathogenesis of a headache attack is the activation and
sensitization of primary afferent neurons (PANs) in the
trigeminovascular system [1-3]. These neurons are pseudounipolar cells, with somata localized in the trigeminal
ganglion (TG) and giving rise to one fiber from which
both the central and peripheral projections derive. The
peripheral fibers innervate the dura mater and cerebral
blood vessels, and the central fibers project to the upper
cervical and medullary dorsal horn. Nociceptive signals
originate from the activation of various chemo- and
mechano-sensors at the peripheral terminals of PANs.
Subsequently, the afferent activity reaches the central
terminals of PANs and activates second-order neurons
in the cervical/medullary dorsal horn, from which the
signals are conveyed to the thalamus and eventually
reach the cortex, where the perception of headache is
formed. Understanding the expression pattern of
chemo-sensing molecules in the PANs of the headache
circuit will add to our understanding of headache pathophysiology and has the potential to facilitate the development of new therapeutics.
Transient receptor potential (TRP) channels are a
large family of non-selective cation channels. Several
TRP channel family members, including TRP cation
channel subfamily V member 1 (TRPV1), subfamily A
member 1 (TRPA1) and TRP channel melastatin 8
(TRPM8), are expressed in distinct populations of PANs
and are activated in response to both temperature
changes and a broad spectrum of endogenous and exogenous chemical ligands [4]. Numerous functional
studies have suggested that these TRP channels mediate
hyperalgesia following tissue and nerve injury and therefore may represent potential targets for novel analgesic
drugs [5]. Thus, it is important to investigate the contribution of these TRP channels to the activation of PANs
in the headache circuit.
In rats, nerve fibers in the dura mater exhibit TRPV1immunoreactivity (TRPV1-ir) [6]. In addition, 97% of
dural afferent fibers in the guinea pig respond to capsaicin [7]. However, the effects of TRPV1 antagonists have
been inconsistent in various in vivo models of headache
[8-10]. Mustard oil, a TRPA1 agonist, evoked inward
currents in 42% of dural afferent neurons in rats [11].
TRPA1 activation has also been shown to mediate dural
vasodilation induced by exposure to nasal irritants
[12,13]. It is unclear whether nasal irritants activate
TRPA1 channels in the dural afferent neurons. In fact,
the expression of TRPA1 channels in dural afferent neurons has not been investigated. One hypothesis is that
nasal irritants excite dural afferent neurons via
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intraganglionic neurotransmission [14-17]. The irritants
would first activate TRPA1 channels on PANs innervating the nasal mucosa, leading to spike generation. Subsequently, this afferent activity would result in the release
of neurotransmitters and neuropeptides from the somata
of nasal afferent neurons [18-22]. This, in turn, crossexcite nearby dural afferent neurons within the TG.
However, the spatial distribution of TRPA1-expressing
(TRPA1+) neurons in the TG has not been studied, nor
do we know their spatial association with dural afferent
neurons. Likewise, whether TRPM8 channels are
expressed in dural afferent neurons and, if so, whether
they play a role in the activation of the trigeminovascular system has not been investigated. It is also important
to characterize both the spatial distribution of TRPM8expressing neurons in the TG and their relationship with
dural afferent neurons.
Various genetically modified mouse models offer great
tools to study the functional significance of TRP channels in headache pathophysiology. Nevertheless, the majority of studies regarding the subpopulations of TG
neurons that project to the dura and cerebral vessels
were conducted in rats and cats. Given the welldocumented differences between rats and mice with respect to the expression of two commonly used PAN
population markers, calcitonin gene-related peptide
(CGRP) and isolectin B4 (IB4) [23], it is important to
quantitatively assess the abundance of TG neuron subpopulations in dural afferents to gain insight into headache mechanisms using mouse models.
In the present study, we used two fluorescent tracers
to retrogradely label dural afferent neurons in adult
mice. We quantified the abundance of peptidergic and
non-peptidergic populations within dural afferents using
CGRP-immunoreactivity (CGRP-ir) and IB4 binding, respectively. We also compared the expression patterns of
TRPV1, TRPA1 and TRPM8 channels in dural afferent
neurons with their patterns in the total TG neuron
population. Our results show that a substantial fraction
of dural afferent neurons bind IB4. Surprisingly, the percentage of dural afferent neurons that exhibit somatic
CGRP-ir is only half that the percentage of the total TG
neuron population. We also found that both TRPV1 and
TRPA1 channels are expressed in dural afferent neurons.
Using nearest-neighbor measurement, we predicted that
TRPA1+ TG neurons are clustered around a subset of
dural afferent neurons and therefore may have a higher
probability of cross-excitation within the TG. Interestingly, TRPM8-expressing TG neurons are virtually absent in the dural afferent population, nor do they cluster
around dural afferent neurons in TG. This lack of smalldiameter TRPM8-expressing neurons may partially account for the larger sizes of dural afferent neurons relative to those of the total TG population.
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Results
Localization and size distribution of dural afferent
neurons in the TG

To label dural afferent neurons, we applied the fluorescent tracer Fluorogold (FG) to the dura above a section
of the superior sagittal sinus (SSS) in adult mice [24].
Retrogradely labeled neurons were observed in the bilateral TG. First, we examined the distribution of labeled
neurons in the ophthalmic (V1), maxillary (V2) and mandibular (V3) divisions of the TG. Consistent with previous reports [25,26], we found that the majority (~70%)
of FG-labeled neurons were localized in the V1 division
of the TG, whereas only a small percentage of labeled
neurons were distributed in the V2 and V3 divisions
(Figure 1A, B and D, black bars, p < 0.001, one-way
ANOVA with post hoc Bonferroni test). To confirm this
result, we retrogradely labeled dural afferent neurons
with another fluorescent tracer, 1,1'-dioctadecyl-3,3,3',3'tetramethylindocarbocyanine perchlorate (DiI) [27]. The
distribution of DiI-labeled dural afferents was similar to
the distribution of FG-labeled neurons, with more than
70% of the labeled neurons localized in the V1 division
of the TG (Figure 1C and D, open bars, p < 0.001, oneway ANOVA with post hoc Bonferroni test, V1 versus V2
or V3 distribution in each group).
Next, we compared the size distribution of dural afferent neurons with the distribution of neurons in the V1/
V2 divisions of the TG. The mean cross-sectional area of
the V1/V2 neurons was 327 ± 4 μm2 (n = 2208 neurons
pooled from three mice). In contrast, the mean crosssectional area of the FG-labeled dural afferents was 374
± 5 μm2 (n = 2316 neurons pooled from three mice),
which was significantly larger than that of the V1/V2 TG
neurons (Figure 1E, F, p < 0.001, Mann–Whitney U test).
This result is in agreement with previous reports regarding the size distribution of PANs innervating the dura
and intracranial vasculature in rats [25,28,29].
It is possible that FG may preferentially label the TG
neurons that have a larger soma diameter, thereby skewing our size comparison between dural afferent neurons
and V1/V2 TG neurons. To address this possibility, we
labeled TG neurons innervating the periorbital skin (between the eyes) with an intradermal injection of FG. As
with the dural afferents, more than 90% of the FGlabeled skin afferent neurons were localized in the V1
division of the TG (Figure 1D, hatched bars, p < 0.001,
one-way ANOVA with post hoc Bonferroni test). The
mean cross-sectional area of the skin afferent neurons
was 319 ± 25 μm2 (n = 600 neurons pooled from three
mice), which is similar to the V1/V2 TG neurons (p = 0.8),
but was significantly smaller than the FG-labeled dural
afferents (Figure 1E, F, p < 0.001, dural versus skin afferents or versus V1/V2 TG neurons, Kruskal-Wallis
ANOVA with Dunn’s post hoc test). We therefore
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conclude that FG labels TG neurons of various soma sizes
with comparable efficiency.
Some recent studies have shown that individual TG
neurons contain collaterals that project to both the meninges and extracranial tissue such as the skull and
muscle [30,31]. We applied DiI to the dura above the
SSS and injected FG into the periorbital skin to label
both dural and skin afferent neurons in individual mice.
We found no overlap between DiI-labeled dural afferent
neurons (n = 425 neurons pooled from three mice) and
FG-labeled skin afferents (n = 360 neurons pooled from
three mice, Figure 2). Our result is consistent with a previous study showing little overlap between the TG neurons that innervate the middle cerebral artery and the
forehead skin in adult rats [25].
The distribution of dural afferent neurons expressing
CGRP

We went on to examine the abundance of TG neurons
subpopulations in the dural afferents. The neuropeptide
CGRP plays an important role in migraine pathophysiology [32,33], and previous studies have shown that the
meninges and cerebral arteries in rodents are densely
innervated by CGRP-expressing (CGRP+) TG neurons
[29,34-36]. The population of TG neurons that project
to the cerebral vasculature contains a higher percentage
of CGRP+ neurons compared with the entire TG [37].
Accordingly, we labeled dural afferent neurons with FG
and stained TG sections using an anti-CGRP antibody
(Figure 3A). CGRP-ir was observed in 32.4 ± 0.8% of the
neurons in the V1/V2 divisions of the TG (Figure 3B,
middle plot). Surprisingly, only 14.9 ± 1.1% of FGlabeled dural afferent neurons displayed CGRP-ir, which
was significantly lower than that of V1/V2 neurons (p <
0.001, Figure 3B, middle plot).
Our results are in apparent disagreement with a previous study of the enrichment of CGRP+ neurons in TG
population projecting to the cerebral vasculature [37].
One possibility may be that relative to other TG neurons, CGRP+ TG neurons may be less efficient at taking
up FG at their terminals and/or transporting FG to the
soma. We labeled TG neurons innervating the periorbital skin with FG and stained the TG sections using the
CGRP antibody. The percentage of CGRP+ neurons in
the FG-labeled skin afferents (30.5 ± 2.8%) was comparable to that of V1/V2 neurons (32.2 ± 0.9%, Figure 3B,
left plot), indicating that FG labels CGRP+ TG neurons
as effectively as those that do not express CGRP.
To test whether CGRP+ dural afferent neurons take up
and/or transport FG less efficiently than other fluorescent tracers, we retrogradely labeled dural afferent neurons with DiI and stained TG tissues using the CGRP
antibody. To better preserve the DiI signal, the concentration of the detergent Triton X-100 in the solutions
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Figure 1 Localization and size distribution of the TG neurons innervating the dura and periorbital skin. (A) Representative image of a TG
section showing FG-labeled (FG+) dural afferent neurons. Note that the labeled neurons are distributed predominantly within the V1 division and
to some extent in the V2 division. (B) High-magnification image of the region indicated in (A). (C) Representative image of DiI-labeled (DiI+) dural
afferent neurons. (D) The distributions of FG+ and DiI+ in the skin and dural afferent neurons from the three TG divisions (n = 3–4 mice in each
group; on average, 200 labeled neurons from each mouse were counted). The majority of labeled neurons are distributed in the V1 and V2
divisions (one-way ANOVA with post hoc Bonferroni test, *** p < 0.001, V1 versus V2 or V3 distribution in each group; # p < 0.05, ### p < 0.001, V2
versus V3 distribution in each group). (E) Histogram of the size distributions of total TG neurons in the V1/V2 divisions, FG+ skin afferent neurons,
and FG+ dural afferent neurons (n = 2316, 600 and 2208 neurons pooled from three mice, respectively). (F) Cumulative distributions of the crosssectional areas of total TG neurons in the V1/V2 divisions, FG+ skin afferent neurons, and FG+ dural afferent neurons (the same neurons as in E).
The sizes of dural afferent neurons are significantly larger than those of the skin afferents and the V1/V2 TG neurons (p < 0.001, Kruskal-Wallis
ANOVA with Dunn’s post hoc test).
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20 µm

Figure 2 Retrograde labeling of dural and facial skin afferent neurons from the same mouse. Representative images of a TG section
showing DiI+ dural afferent neurons (A) and FG+ neurons innervating the periorbital skin (B). Note that there is no overlap between the dural and
skin afferent neurons as seen in the merged image (C) A total of 425 dural and 360 skin afferent neurons from three mice were counted,
respectively).

was decreased from 0.3% to 0.03% [38]. CGRP-ir was
observed in 32.3 ± 1.1% of the V1/V2 TG neurons
(Figure 3B, right plot), indicating that the low triton concentration did not compromise the sensitivity of the
immunostaining. Only 15.3 ± 1.4% DiI-labeled dural afferent neurons exhibited CGRP-ir (p < 0.001, Figure 3B,
right plot), which is in agreement with the results
obtained from the FG-labeled dural afferent neurons.
Taken together, we conclude that the percentage of dural
afferent neurons exhibiting somatic CGRP-ir is significantly smaller than that of neurons in the V1/V2 TG
divisions.
Both small- (< 600 μm2 cross-sectional area) and
medium-sized (600–1400 μm2 cross-sectional area) TG
neurons expressed CGRP (Figure 3C, D, open bars). The
mean cross-sectional area of the CGRP+ neurons in the
V1/V2 TG divisions was 417 ± 14 μm2 (n = 661 neurons
pooled from three mice). The mean cross-sectional area
of the CGRP+ neurons innervating the dura was 373 ±
10 μm2 (n = 99 neurons pooled from three mice;
Figure 3C, E, black bars), which was comparable to the
size of the CGRP+ neurons in the V1/V2 TG divisions
(p = 0.7, Mann–Whitney U test, Figure 3C). Therefore,
both small- and medium-sized dural afferent neurons
express CGRP, albeit all at a lower abundance relative
to the total TG neuronal population.
The distribution of dural afferent neurons that bind IB4

IB4 binding is commonly used to define the nonpeptidergic population of primary afferents, i.e., sensory
neurons that express little or very low levels of neuropeptides [39,40]. We labeled dural afferent neurons with
FG and stained the sections with Alexa Fluor 594conjugated IB4 (Figure 4A). In the V1/V2 divisions of the
TG, 45.5 ± 2.2% of the neurons were labeled with IB4
(IB4+). The percentage of IB4+ neurons in the dural
afferents was 38.0 ± 0.7%, significantly lower than that
in the V1/V2 divisions (Figure 4B, p < 0.05). The size distribution of the IB4+ dural afferents was similar to the
total IB4+ population of neurons in the V1/V2 divisions
of the TG (p = 0.1, Mann–Whitney U test, Figure 4C).

The mean cross-sectional area of the IB4+ neurons in
the V1/V2 divisions of the TG was 327 ± 14 μm2 (n = 686
neurons pooled from three mice). More than 95% of the
IB4+ neurons had a cross-sectional area smaller than
600 μm2, which is consistent with previous studies and
indicated that these neurons belong to the small-sized TG
population (Figure 4D, p < 0.001 compared with total V1/
V2 TG neurons, Mann–Whitney U test). The mean crosssectional area of the IB4+ neurons in the dural afferents
was 316 ± 13 μm2 (n = 267 neurons pooled from three
mice), which was significantly smaller than that of the
entire FG-labeled population (Figure 4E, p < 0.001,
Mann–Whitney U test).
The distribution of TRPV1 channels in TG and dural
afferent neurons

TRPV1 channels can be activated by noxious heat as
well as by chemical ligands, including capsaicin, anandamide, and protons [41]. TRPV1-ir and sensitivity to capsaicin have been reported in dural afferent neurons from
rats and guinea pigs, respectively [6,7]. Here, we investigated whether the distribution of TRPV1 channels in
dural afferent neurons differs from their distribution in
total TG tissue in mice.
We labeled the dural afferent neurons with FG and
stained TG sections with an antibody against TRPV1
channels (Figure 5A). TRPV1-ir was present in 31.0 ±
0.6% of the neurons in the V1/V2 divisions of the TG, a
significantly higher percentage than in the V3 division
(21.0 ± 0.3%, p < 0.001, Figure 5B). In addition, 23.7 ±
2.1% of the FG-labeled dural afferent neurons exhibited
TRPV1-ir (Figure 5C), in line with a previous study [6].
The percentage of TRPV1-expressing (TRPV1+) neurons in the dural afferent neurons was significantly
lower than in the total V1/V2 TG population (Figure 5C,
p < 0.05).
The size distribution of the TRPV1+ dural afferents
was similar to that the distribution of the TRPV1+ neurons in the V1/V2 divisions of the TG (p = 0.1, Mann–
Whitney U test, Figure 5D). The mean cross-sectional
area of the TRPV1+ neurons in V1/V2 was 215 ± 4 μm2
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(See figure on previous page.)
Figure 3 The distribution of dural afferent neurons expressing the neuropeptide CGRP. (A) Representative images of TG sections
containing FG+ or DiI+ dural afferent neurons and neurons exhibiting CGRP-ir. Arrowheads indicate double-labeled FG+/CGRP+ and DiI+/CGRP+
dural afferent neurons. (B) The abundances of CGRP+ neurons in the V1/V2 divisions of the TG, in the FG+ skin afferent neurons, and in the FG+ or
DiI+ dural afferent neurons (n = 3 mice in each group; *** p < 0.001, two-tailed t-test). On average, 685 V1/V2 neurons from each mouse were
counted in each group. On average, 296 FG+ skin afferent neurons, 233 FG+ dural afferents, and 285 DiI+ dural afferent neurons were counted
from each mouse. (C) The size distribution of the CGRP+ dural afferent neurons (filled bars, n = 99 neurons pooled from three mice) is similar to
that of the CGRP+ neurons in the V1/V2 divisions of the TG (open bars, n = 661 neurons pooled from three mice, p = 0.7, Mann–Whitney U test).
(D) The size distribution of the CGRP+ neurons (open bars, the same neurons as in C) and total neurons in the V1/V2 divisions of the TG (grey
bars, n = 2041 neurons pooled from three mice). (E) The size distribution of the CGRP+ dural afferent neurons (filled bars, the same neurons as in
C) and total FG+ dural afferents (grey bars, n = 700 neurons pooled from three mice).

(n = 679 neurons pooled from three mice), which was
significantly smaller than that of the total V1/V2 TG
neuron population (327 ± 11 μm2, n = 2189 neurons
pooled from three mice, p < 0.001, Mann–Whitney U
test, Figure 5E). This finding is consistent with previous
reports showing that TRPV1 is expressed almost exclusively in small-diameter c-fiber neurons [42,43]. The
mean cross-sectional area of the TRPV1+ dural afferent
neurons (228 ± 5 μm2, n = 151 neurons pooled from
three mice) was also significantly smaller relative to the
entire FG-labeled population (325 ± 13 μm2, n = 638
neurons pooled from three mice, Figure 5F, p < 0.001,
Mann–Whitney U test).
The distribution of TRPA1 channels in TG neurons and
dural afferent neurons

TRPA1, another TRP channel family member, has been
reported to sense noxious cold stimuli [44,45] (but see
[46]). In addition, previous studies have shown that
TRPA1 channels act as the sensor of a broad spectrum
of endogenous compounds as well as environmental irritants [47-50]. The TRPA1 agonist mustard oil evokes inward currents in a subset of rat dural afferent neurons
[11], and recent studies have shown that the intranasal
application of TRPA1 agonists induces dural vasodilation
[12,13]. Here, we quantified the distribution of TRPA1
channels in mouse dural afferent neurons.
We labeled the dural afferent neurons with FG and
stained TG sections with anti-TRPA1 antibodies
(Figure 6A, [51]). Within the three TG divisions,
TRPA1-immunoreactivity (TRPA1-ir) was distributed
uniformly in a very small population of TG neurons
(Figure 6B). We found that 5.7 ± 0.5% of the FG-labeled
dural afferent neurons were positive for TRPA1-ir, which
is similar to the percentage of TRPA1+ neurons in the
total V1/V2 TG neuron population (7.5 ± 0.7%,
Figure 6C).
The mean cross-sectional area of the TRPA1+ neurons
in V1/V2 was 262 ± 8 μm2 (n = 130 neurons pooled from
three mice), which is significantly smaller than that of
the total V1/V2 TG neurons (325 ± 11 μm2, n = 1729
neurons pooled from three mice, p < 0.001, Mann–

Whitney U test, Figure 6E). In fact, 97% of the TRPA1+
neurons had a cross-sectional areas that was smaller
than 500 μm2 (Figure 6D, E, open bars), which is consistent with previous reports indicating that TRPA1 is
predominantly expressed in small-diameter primary afferent neurons [43,45-47,51,52] (but see [53]). The mean
cross-sectional area of the TRPA1+ dural afferent neurons (222 ± 9 μm2, n = 35 neurons pooled from three
mice) was significantly smaller than that of the entire
FG-labeled neuron population (324 ± 20 μm2, n = 620
neurons pooled from three mice, Figure 6F, p < 0.001,
Mann–Whitney U test). Interestingly, the sizes of the
TRPA1+ dural afferent neurons were also significantly
smaller than those of the TRPA1+ neurons in the V1/V2
divisions of the TG (Figure 6D, p < 0.05, Mann–Whitney
U test).
Recent studies have shown that the intranasal administration of TRPA1 agonists stimulates CGRP release and
increases meningeal blood flow, suggesting that these
events may contribute to the onset of headaches triggered by environmental irritants [12,13]. It has been suggested that TRPA1+ neurons innervating the nasal
mucosa may cross-excite nearby dural afferent neurons
within the TG via intraganglionic neurotransmission
[14-22]. Here, we used nearest-neighbor measurement
to determine whether TRPA1+ neurons are clustered
around dural afferent neurons (or vice versa) [54,55].
First, we tested whether dural afferent neurons are
randomly distributed in the V1/V2 divisions of the TG or
are clustered. Thus, for each FG-labeled neuron, we
measured the distance to the nearest FG-labeled neuron.
This analysis allowed us to calculate the value of rA, the
mean distance to the nearest neighbor between FGlabeled neurons in each mouse. We then calculated R,
the ratio of rA to rE, where rE is the mean distance to
the nearest neighbor expected from a randomly distributed population of FG-labeled neurons. The value of R
can vary from 0 (for a distribution with maximum aggregation) to 2.1491 (for a perfectly uniform distribution).
An R value of 1 corresponds to a random distribution of
the cell population. The value of c, the standard variate
for the normal curve, corresponds to the significance of
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Figure 4 The distribution of IB4+ neurons in the V1/V2 TG divisions and the dural afferent population. (A) Representative images of a TG
section containing FG+ dural afferent neurons and IB4-labeled neurons. Arrowheads indicate neurons that are both FG+ and IB4+. (B) The
percentages of V1/V2 TG neurons and FG+ dural afferent neurons that are IB4+ (n = 3 mice; on average, 500 V1/V2 neurons and 235 FG+ neurons
were counted from each mouse; * p < 0.05, two-tailed t-test). (C) The size distributions of the IB4+/FG+ dural afferent neurons (black bars, n = 267
neurons pooled from three mice) are similar to the distributions of the IB4+ neurons in the V1/V2 divisions of the TG (white bars, n = 686 neurons
pooled from three mice, p = 0.1, Mann–Whitney U test). (D) The sizes of IB4+ neurons (open bars, the same neurons as in C) are significantly
smaller than those of the V1/V2 neurons (grey bars, n = 1499 neurons pooled from three mice, p < 0.001, Mann–Whitney U test). (E) The sizes of
IB4+/FG+ dural afferents (black bars, the same neurons as in C) are significantly smaller than those of the total FG+ dural afferent neurons (grey
bars, n = 704 neurons pooled from three mice, p < 0.001, Mann–Whitney U test).

a departure from the expected value of R = 1. The c
values of 1.96 and 2.58 represent the 0.05 and 0.01 probability levels of statistical significance for measurements
of a given population, respectively [54]. The R values of

the dural afferent neurons from three mice were all close
to 1, and their c values were all lower than 1.96
(Figure 6G), indicating that dural afferent neurons are
randomly distributed in the V1/V2 divisions of the TG.
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Figure 5 The distribution of neurons expressing TRPV1 channels in the TG and dural afferent neuron populations. (A) Representative
images of a TG section containing FG+ dural afferent neurons and neurons exhibiting TRPV1-ir. Arrowheads indicate neurons that are both FG+
and TRPV1+. (B) The percentage of TRPV1+ TG neurons in the V1/V2 and V3 divisions (n = 3 mice; on average, 730 V1/V2 neurons and 500 V3
neurons were counted from each mouse; *** p < 0.001, two-tailed t-test). (C) The percentages of V1/V2 TG neurons (the same data set as in B)
and FG+ dural afferent neurons that are TRPV1+ (n = 3 mice, on average, 213 FG+ neurons were counted from each mouse; * p < 0.05, two-tailed
t-test). (D) The size distribution of TRPV1+/FG+ dural afferent neurons (n = 151 neurons pooled from three mice) are similar to the TRPV1+
neurons in the V1/V2 divisions of the TG (n = 679 neurons pooled from three mice, p = 0.1, Mann–Whitney U test). (E) The sizes of TRPV1+
neurons (the same neurons as in D) are significantly smaller than those of the neurons in the V1/V2 divisions of the TG (n = 2189 neurons pooled
from three mice, p < 0.001, Mann–Whitney U test). (F) The sizes of TRPV1+/FG+ dural afferents (the same neurons as in D) are significantly smaller
than those of the total FG+ dural afferent neurons (n = 638 neurons pooled from three mice, p < 0.001, Mann–Whitney U test).
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(See figure on previous page.)
Figure 6 The distribution of neurons expressing TRPA1 channels in the TG and dural afferent neurons. (A) Representative images of a TG
section containing a FG+/TRPA1+ dural afferent neuron (indicated by the arrowheads; scale bar: 20 μm). (B) The percentage of TRPA1+ TG
neurons in the V1/V2 and V3 divisions (n = 3 mice; on average, 576 V1/V2 neurons and 428 V3 neurons were counted from each mouse). (C) The
percentages of TRPA1+ V1/V2 TG neurons (the same data as in B) and FG+ dural afferent neurons (n = 3 mice, on average, 206 FG+ neurons were
counted from each mouse). (D) The size distribution of TRPA1+/FG+ dural afferent neurons are significantly smaller than those of the TRPA1+
neurons in the V1/V2 divisions of the TG (n = 35 and 130 neurons pooled from three mice, respectively; p < 0.05, Mann–Whitney U test). (E) The
sizes of TRPA1+ neurons (the same neurons as in D) are significantly smaller than those of the neurons in the V1/V2 divisions of the TG (n = 1729
neurons pooled from three mice, p < 0.001, Mann–Whitney U test). (F) The sizes of TRPA1+/FG+ dural afferents (the same neurons as in D) are
significantly smaller than those of the total FG+ dural afferent neurons (n = 620 neurons pooled from three mice, p < 0.001, Mann–Whitney U
test). (G) Nearest-neighbor measurement shows that both FG+ dural afferent neurons and TRPA1+ neurons are randomly distributed in the TG (n
= 130 TRPA1+ neurons and 620 FG+ dural afferent neurons from 3 mice, the same cells as in D and F). (H) A modified nearest-neighbor
measurement shows that TRPA1+ neurons are clustered around some, but not all, of the FG+ dural afferent neurons (the same neurons as in G).

This finding is consistent with a previous study showing
a random distribution of TG neurons innervating the
middle cerebral arteries in rats [25]. Secondly, we examined the spatial distribution of the TRPA1+ neurons in
the V1/V2 divisions of the TG. As with the dural afferent
neurons, the mean R value for the TRPA1+ neurons was
also close to 1, suggesting that the TRPA1+ neurons are
randomly distributed in the V1/V2 TG divisions
(Figure 6G).
We proceeded to examine the spatial association between FG-labeled dural afferent neurons and TRPA1+
neurons using a modified nearest-neighbor measurement [55]. First, we tested whether TRPA1+ neurons are
clustered around dural afferent neurons more than
would be expected from a random distribution. We
measured the distance (r) between each FG-labeled dural
afferent neuron and its nearest TRPA1+ neuron and calculated the average nearest-neighbor distance (rA). We
then computed the value of R, the ratio of rA to rE,
where rE indicates the mean value of r for complete
spatial independence between dural afferent neurons
and TRPA1+ neurons. An R value of 1 indicates a lack of
association (spatial independence) between the two cell
populations, whereas an R value less than or greater
than 1 suggests that the TRPA1+ TG neurons are more
clustered than random (i.e., aggregation) or are more
regularly distributed than random (i.e., avoidance), respectively, with respect to the FG-labeled neurons. The
R values of three different mice were all greater than 1
(1.24 ± 0.15, Figure 6H). We tested the significance of
this departure from spatial independence (i.e., R = 1) by
calculating c, the standard variate of the normal curve.
A mentioned above, c values of 1.96 or 2.58 represent
the 0.05 and the 0.01 levels of significance for a twotailed test, respectively [54,55]. The c values from three
different mice were all greater than 2.4 (p < 0.05), suggesting that the TRPA1+ neuron population is distributed farther away from the dural afferent population than
would be predicted by random association.
Since the number of FG-labeled neurons was approximately 2–3 fold greater than the number of TRPA1+

neurons in each TG section, we tested whether the
TRPA1+ neurons cluster around a subgroup of dural afferent neurons but not the entire dural afferent population. Accordingly, we measured the distance between
each TRPA1+ neuron and its nearest FG-labeled neuron
and calculated the value of R as a measure of the spatial
association. The R values obtained from three mice ranged from 0.46 to 0.74 (Figure 6H). The c values from
these three mice were all greater than 7.5 (p < 0.0001),
indicating a significant departure from spatial independence, leading to aggregation.
How close are the TRPA1+ neurons to their nearest
FG-labeled dural afferent neuron? We found that the
mean distance between the TRPA1+ neurons and the
nearest FG-labeled neuron was 56 ± 2 arbitrary units
(measured between the centers of the two cells). This
distance was 1.7 ± 0.1 fold the mean distance between
the TRPA1+ neurons and their closest neuron (32 ± 1 arbitrary units). Thus, there was approximately one
neuron separating each TRPA1+ neuron from its nearest
FG-labeled dural afferent neuron. On the other hand, we
found that the mean distance between the closest pairs
of TRPA1+ neurons or pairs of FG-labeled dural afferents was significantly greater than the distance between
the TRPA1+ neurons and their closest FG-labeled
neuron (101 ± 3 versus 77 ± 5 arbitrary units, respectively; p < 0.05, one-way ANOVA with post hoc Bonferroni test). Taken together, we conclude that the TRPA1+
neurons are clustered around some, but not all, of the
dural afferent neurons in the TG. It is possible that the
neurotransmitters and neuropeptides that are released
from the soma of TRPA1+ neurons have a higher likelihood of cross-exciting this subpopulation of dural afferent neurons within the TG.
TRPM8 channels are not expressed in dural afferent
neurons

TRPM8 channel is a member of thermo-TRP family and
transduces the cooling and cold sensations in mice [5660]. Previous studies indicated that TRPM8-expressing
neurons innervate both the skin and visceral organs [61-
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63]. Here, we used mice expressing farnesylated
enhanced green fluorescent protein (EGFPf ) at one
TRPM8 locus (TRPM8EGFPf/+, [61]) to investigate
whether TRPM8 is expressed in dural afferent neurons.
All of the EGFPf-expressing (EGFPf+) dorsal root ganglion (DRG) neurons from TRPM8EGFPf/+ mice respond
to both cold and menthol, indicating that the EGFP signal corresponds well with endogenous TRPM8 expression [61].
We used DiI to retrogradely label the dural afferent
neurons in TRPM8EGFPf/+ mice. Remarkably, we found
an almost complete segregation of EGFPf fluorescence
and the DiI signal in the TG (Figure 7A, B). In fact, of
the 619 DiI-labeled dural afferent neurons measured
from three TRPM8EGFPf/+ mice, only three neurons were
EGFPf+. To determine whether this segregation is due to
a lack of TRPM8-expressing neurons in the V1/V2 TG
divisions, we examined both the distribution and abundance of EGFP+ neurons in all of the TG divisions of the
TRPM8EGFPf/+ mice. Of all of the EGFPf+ neurons that
we counted, approximately half were localized in the V3
division of the TG, and the remaining half were distributed uniformly between the V1 and V2 divisions
(Figure 7C, p < 0.001 compared with the V3 division,
one-way ANOVA with post hoc Bonferroni test). This
result is in agreement with a previous report that
TRPM8 expression is enriched in the V3 division of the
TG [43]. We next measured the abundance of EGFPf+
neurons in the TG divisions. The percentages of TG
neurons expressing EGFPf were similar between the V1/
V2 and V3 divisions (12.6 ± 0.9% and 12.9 ± 0.4%, respectively, Figure 7B). Thus, it is unlikely that the lack of
EGFPf+ neurons in the dural afferents arose from a low
abundance of TRPM8-expressing neurons in the V1/V2
TG divisions. Notably, the overall abundance of EGFPf+
neurons in the TG was consistent with previous studies
using anti-TRPM8 antibodies [56,64], further validating
the EGFPf signal as a marker of endogenous TRPM8
expression.
To test whether TRPM8-expressing neurons are deficient in either their ability to take up DiI at terminals
and/or transporting DiI to the soma, we injected DiI
into the skin over the whisker pad in TRPM8EGFPf/+
mice. The percentage of EGFPf+ neurons in the DiIlabeled skin afferents (11.3 ± 1.3%) was comparable to
that of the V1/V2 neurons (12.8 ± 0.9%, Figure 7A, D),
indicating that EGFPf+ neurons take up and transport
DiI as efficiently as other TG neuron populations.
We showed above that the sizes of the dural afferent
neurons are significantly larger than those of the V1/V2
TG neurons (Figure 1E, F). We wondered whether this
difference stems from an absence of TRPM8-expressing
neurons in the dural afferents. To address this question,
we examined the size distribution of EGFPf+ neurons in
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the V1/V2 division of TG. The mean cross-sectional area
of the EGFPf+ neurons in the V1/V2 was 223 ± 11 μm2
(n = 363 neurons pooled from five mice), which was significantly smaller than that of the total V1/V2 TG
neuron population (339 ± 1 μm2, n = 2403 neurons
pooled from five mice, p < 0.001, Mann–Whitney U test,
Figure 7E). This result is consistent with previous
reports that TRPM8 is expressed predominantly in
small-diameter primary afferent neurons [45,59-62,64].
This finding led us to predict that the absence of
TRPM8-expressing neurons in the dural afferent population could shift its size distribution towards the size of
the EGFPf-negative (EGFPf−) V1/V2 TG neurons. Because the DiI-labeled neurons exhibited a punctate pattern of fluorescence, we found it difficult to accurately
calculate their cross-sectional area. We therefore compared the sizes of the total and the EGFPf− V1/V2 TG
neurons with the sizes of the FG-labeled dural afferent
neurons (the solid black line in Figure 1F). As expected,
the sizes of the EGFPf− V1/V2 TG neurons were similar
to those of the FG-labeled dural afferent neurons
(Figure 7F, p = 0.95, Kruskal-Wallis ANOVA with
Dunn’s post hoc test); however, both neuron populations
were significantly larger than the total V1/V2 neuron
population (p < 0.001). Taken together, our results indicate that more than 10% of the neurons in the TG have
a small-diameter soma and express TRPM8 but do not
innervate the dura. This finding may account for the larger sizes of dural afferent neurons relative to the sizes of
the total V1/V2 TG neuron population.
We proceeded to assess the spatial distribution of the
DiI-labeled dural afferent neurons and the EGFPf+ neurons in the V1/V2 divisions of the TG using nearestneighbor measurement [54]. The R values of the dural
afferent neurons as well as the EGFPf+ neurons were all
close to 1 (Figure 7G), and the c values were all less than
1.96, indicating that both the dural afferent neurons and
the TRPM8-expressing neurons are distributed randomly
in the V1/V2 divisions of the TG. We then investigated
the spatial association between the DiI+ dural afferent
neurons and the EGFPf+ neurons using the modified
nearest-neighbor measurement [55]. We first tested
whether the EGFPf+ neurons were randomly distributed,
were more clustered than random (i.e., aggregation), or
were more regularly distributed than random (i.e., avoidance) relative to the DiI-labeled dural afferent neurons.
As shown in Figure 7H, the R values from three separate
mice were all greater than 1 (1.32 ± 0.11), and the c
values were all greater than 5.8 (p < 0.001), suggesting
that the EGFPf+ neurons are located further from the
dural afferent population than would be predicted by
random association. Next, we tested whether the EGFPf+
neurons are more clustered around a subpopulation of
dural afferent neurons (as is the case for the TRPA1+
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Figure 7 The dural afferent neuron population lacks TRPM8-expressing neurons. (A) Representative images of TG sections from TRPM8EGFPf/+
mice following dural DiI application or intradermal DiI injection at the whisker pad. The thick and thin arrowheads indicate DiI+ and EGFPf+
neurons, respectively. The arrows in the lower row indicate a DiI+ skin afferent neuron that is also EGFPf+. (B) The percentage of EGFPf+ neurons
that are in the V1/V2 TG, the V3 TG and the DiI+ dural afferent neuron population (n = 3 mice, on average, 480 V1/V2 neurons, 472 V3, neurons
and 206 DiI+ neurons were counted from each mouse; *** p < 0.001, two-tailed t-test, V1/V2 group versus DiI+ dura group). (C) The fraction of
EGFPf+ neurons in the three TG divisions (n = 4 mice; on average, 1210 EGFPf+ neurons were counted from each mouse; *** p < 0.001, one-way
ANOVA with post hoc Bonferroni test, all compared with the V3 distribution). (D) The percentage of EGFPf+ V1/V2 TG neurons and DiI+ neurons
innervating the skin over the whisker pad (n = 4 mice, on average, 448 V1/V2 neurons and 76 DiI+ neurons were counted from each mouse). (E)
The sizes of EGFPf+ neurons (n = 363 neurons pooled from five mice) are significantly smaller than those of the neurons in the V1/V2 divisions of
the TG (n = 2403 neurons pooled from 5 mice, p < 0.001, Mann–Whitney U test). (F) Cumulative distributions of the cross-sectional areas of the
total TG neuron populations in the V1/V2 divisions (the same neurons as in E), the EGFPf− V1/V2 TG neurons (n = 2040 neurons pooled from five
mice), and the FG+ dural afferent neurons (the same neurons as in Figure 1F). The sizes of EGFPf− V1/V2 TG neurons are comparable to those of the
dural afferent neurons, and both populations are significantly larger than the total V1/V2 neurons (p < 0.001, Kruskal-Wallis ANOVA with Dunn’s
post hoc test). (G) Nearest-neighbor measurement shows that both DiI+ dural afferent neurons and EGFPf+ neurons are randomly distributed in the
TG (n = 182 EGFPf+ neurons and 619 DiI+ dural afferent neurons from three mice, the same neurons as in B). (H) A modified nearest-neighbor
measurement shows that the EGFPf+ neurons are located farther away from the dural afferent population than would be predicted by random
association, and vice versa (the same neurons as in G).
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neurons). Accordingly, we measured the distance between each EGFPf+ neuron and its nearest DiI-labeled
neuron and then calculated the R value. The R values
obtained from three mice were all greater than 1 (1.17 ±
0.02, Figure 7H), and the c values were all greater than
3.1 (p < 0.01). In fact, the mean distance between the
EGFPf+ neurons and their nearest DiI-labeled neuron
was 163 ± 11 arbitrary units, which is 3.9 ± 0.3 fold
greater than the mean distance between the EGFPf+
neurons and their adjacent neuron (33 ± 2 arbitrary
units). Taken together, we conclude that TRPM8expressing neurons and dural afferent neurons are
located farther away from each other than would be
predicted by random association in the V1/V2 divisions
of the TG. It is therefore unlikely that these two populations of neurons cross-excite each other within
the TG.

Discussion
In this study, we used two fluorescent tracers, FG and
DiI, to retrogradely label dural afferent neurons in adult
mice. This approach allowed us to quantitatively compare both the size distribution and the protein expression profiles of dural afferent neurons with those of the
total TG neuron population and the facial skin afferents.
Our results show that the TG neurons that innervate the
dura over the SSS are predominantly localized in the V1/
V2 divisions of the TG. The sizes of dural afferent neurons in mice are significantly larger than those of the
V1/V2 TG neurons and the facial skin afferents, which is
consistent with previous studies using rats [25,28,29].
A substantial percentage of dural afferent neurons
bind IB4, suggesting that these neurons belong to the
non-peptidergic PAN population. These neurons likely
express P2X3 receptors and mediate the pronociceptive
effects of ATP [65]. In contrast, the percentage of CGRP+
dural afferent neurons (~15%) was only half those of
the V1/V2 TG neurons or the facial skin afferents. We
excluded the possibility that this result is due to a low
efficiency of CGRP+ neurons to take up FG and DiI at
their terminals and/or transport the tracers to the soma.
Our result is in contrast with a previous study quantifying the abundance of CGRP+ neurons in TG neurons
that innervate the intracranial arteries in rats [37].
O’Connor and van der Kooy (1988) reported that 32% of
the TG neurons that project to the cerebral vasculature
express CGRP, which is much higher than the 23% of
CGRP+ neurons that was observed in the entire TG. Differences in the animal species (rat versus mouse) and
target tissues (cerebral vasculature versus dura) between
the two studies may account for this discrepancy. We
suspect that one crucial difference may be the way in
which the tissue was prepared prior to immunostaining
with the anti-CGRP antibody. In the previous study, the
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TG tissues were organ-cultured in serum-free medium
containing colchicine for 9–12 hours before fixation and
immunostaining. The colchicine pretreatment and/or
the organ culture procedure per se may have preferentially increased the CGRP levels in the TG neurons that
innervate cerebral arteries. Indeed, recent studies have
shown enhanced CGRP expression in rat TG neurons
during cell and organ cultures in serum-free medium
[66,67]. On the other hand, in our approach, we may
have underestimated the number of CGRP+ neurons in
the dural afferents. It is possible that dural afferent neurons exhibit enhanced trafficking of CGRP-containing
vesicles towards the terminals and/or have enhanced
exocytosis of CGRP, either of which could result in a depletion of somatic CGRP stores. The dense innervation
of CGRP+ fibers at the meninges and cerebral arteries in
rodents is well-documented [29,34-36]. On the other
hand, acutely-dissociated dural afferent neurons do not
exhibit spontaneous action potential firing [27]. In fact,
injection of a depolarizing current elicits a significantly
higher number of action potentials in skin afferent neurons than in dural afferents, suggesting the lower excitability of the latter population [68]. This argues against
enhanced exocytosis in dural afferent neurons. Further
work is needed to resolve the discrepancy between our
data and previous studies.
The primary purpose of this study was to quantitatively evaluate the expression of TRPV1, TRPA1, and
TRPM8 channels in dural afferent neurons. First, we
found that the percentages of TG neurons that express
these channels are consistent with previous studies
[7,43,45,51,52,56,58-60,64]. The size distributions of
TRPV1+, TRPA1+, and TRPM8-expressing TG neurons
were also similar to previous reports. As summarized in
Figure 8, the sizes of TRPV1+ neurons are the smallest
among the three populations of TG neurons (p < 0.001
and p < 0.05 compared with the TRPA1+ and EGFPf+
groups, respectively). The cross-sectional areas of the
TRPA1+ neurons are significantly larger than those of
the TRPV1+ and TRPM8-expressing neurons (p < 0.001
and p < 0.05, respectively, Kruskal-Wallis ANOVA with
Dunn’s post hoc test) neurons. This finding is consistent
with previous reports that TRPA1 is expressed in the
subpopulation of TRPV1 neurons that have a relatively
large diameter soma [45,69]. Secondly, the percentage of
TRPV1+ dural afferent neurons in our study is similar to
that in a previous report [6] but is ~20% lower than that
in the total V1/V2 TG neuron population. On the other
hand, the percentage of TRPA1+ neurons in the dural
afferents is comparable to that in the V1/V2 TG population. Taken together, our results suggest that compared
with total TG neurons, dural afferent neurons contain a
smaller fraction of TRPV1+ cells that do not express
TRPA1 channels.
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Figure 8 Overlay of the cumulative distributions of the TRPV1+,
TRPA1+ and TRPM8-expressing neurons in the V1/V2 divisions
of the TG. Cumulative distribution of the cross-sectional areas of the
total TG neurons in the V1/V2 divisions (dashed gray line, the same
neurons as in Figure 1F), the TRPV1+ neurons (solid black line, the
same neurons as in Figure 5E), the TRPA1+ neurons (red line, the
same neurons as in Figure 6E), and the TRPM8-expressing neurons
(dashed green line, the same neurons as in Figure 7E). A KruskalWallis ANOVA with Dunn’s post hoc test reveals that the sizes of
TRPV1+ neurons are the smallest of the three populations of TG
neurons (p < 0.001 and p < 0.05 compared with the TRPA1+ and
EGFPf+ groups, respectively). In contrast, the sizes of TRPA1+ neurons
are significantly larger than those of the TRPV1+ and TRPM8expressing neurons (p < 0.001 and p < 0.05, respectively).

A noteworthy finding in this study is the absence of
TRPM8-expressing neurons in the dural afferent population, despite the fact that TRPM8 is expressed in
more than 10% of both the total and skin afferent TG
neurons. This may, at least partially, account for the
difference in size distribution between the dural afferents and the total TG neurons. Furthermore, results
from our nearest-neighbor measurement predicte that
TRPM8-expressing neurons and dural afferent neurons
are farther away from each other than would be predicted by random association, suggesting that TRPM8
channels may have only a small, or no, contribution to
the activation of PANs in the headache circuit. On the
contrary, not only are TRPA1 channels expressed in a
small population of dural afferent neurons, TRPA1+
neurons are also clustered around some, but not all,
dural afferent neurons in the TG. Previous studies have
shown that stimulating PANs elicits the somatic release
of ATP, substance P, and CGRP [18-22]. These somatically released neurotransmitters and neuropeptides may
account for the cross-depolarization and crossexcitation between PANs that have been observed in rat
DRG and nodose ganglia [14-17]. Our data suggest that
TRPA1 channels may directly excite dural afferent neurons as well as play a role in the intraganglionic cross-

excitation of dural afferents. These results are in agreement with recent studies showing that the intranasal
administration of TRPA1 agonists stimulates CGRP release and increases meningeal blood flow [12,13]. Our
results provide anatomical evidence to support a possible scenario by which TRPA1+ neurons innervating
the nasal mucosa may cross-excite nearby dural afferent
neurons. Future experiments are necessary to directly
test this possibility.
That said, it is possible that our method may not have
been sufficiently sensitive to detect low expression levels
of TRPM8 and/or TRPA1 channels in the TG and dural
afferent neurons. Indeed, an in situ hybridization study
showed a low level of TRPM8 expression in mediumsized DRG neurons in rats [43]; in our study, all of the
EGFPf+ neurons belonged to the small-sized TG population (< 600 μm2 cross-sectional area; Figure 7E). The
abundance of TRPA1 channels in our study (in 6 ~ 7%
of the TG neurons; Figure 6B, C) is consistent with some
of previous results [45,51] but is much lower than the 20
~ 25% that has been reported in other studies [44,46,47].
Kwan et al. measured Trpa1 mRNA and found that
mouse DRG neurons of all sizes express TRPA1 [53].
Moreover, a recent functional study found that 40% of
rat dural afferent neurons respond to TRPA1 agonists
[11]. Thus, it is possible that the TRPA1+ population in
our study preferentially contains neurons that express
high levels of TRPA1 channels. Taken together, whether
and how various TRP channels contribute to the activation and/or sensitization of PANs in the headache circuit
merits further investigation. Our study has established
an anatomical foundation upon which mouse models
can be used to address the role of TRP channels in headache pathophysiology.

Conclusions
In this study, we have quantitatively measured the size
distributions and protein expression profiles of dural afferent neurons in adult mice. We provide evidence that
a substantial fraction of dural afferent neurons bind IB4,
whereas the percentage of CGRP+ dural afferent neurons
is significantly lower than in total TG neuron population. Both TRPV1 and TRPA1 channels are expressed in
dural afferent neurons. In addition, TRPA1+ neurons are
clustered around a subset of dural afferent neurons, suggesting that they may have a higher probability of generating cross-excitation within the TG. Interestingly,
TRPM8-expressing neurons are virtually absent in the
dural afferent population, nor do they cluster around
dural afferent neurons. We postulate that this lack of
TRPM8-expressing neurons may partially account for
the larger sizes of dural afferent neurons relative to
those of the total TG neuron population.
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Methods
Experimental animals

Eight-to-twelve-week old mice on a C57BL/6 background were used in this study. The care and use of
mice were in accordance with the guidelines of the Animal Study Committee at Washington University in St.
Louis. Hemizygous mice expressing EGFPf at the
TRPM8 locus were obtained by crossing heterozygous
breeders. Mice were genotyped by PCR of their tail
DNA as described previously [61].
Retrograde labeling of TG neurons innervating the dura
or the facial skin

Mice were anesthetized with 3-4% isoflurane in an induction chamber until the loss of the righting reflex.
The mice were then mounted on a Stoelting stereotaxic
apparatus and placed on a 37 °C circulating water warming pad to maintain core body temperature. Anesthesia
was maintained by 1.5-2% isoflurane through a nose
cone. A longitudinal skin incision was made to expose
the cranium, and a craniectomy (~2 mm in diameter)
was made using a cooled dental drill in the skull overlying the SSS, leaving the underlying dura exposed but intact. Topical lidocaine was applied to the skin and skull
to prevent the activation and/or sensitization of the primary afferent neurons. To prevent spreading of the
tracer to other peripheral sites, a sterile polypropylene
ring was sealed to the skull surrounding the exposed
dura using a mixture of dental cement powder (Stoelting
51459) and superglue adhesive [70]. The viscosity of the
dental cement/superglue mixture prevented spreading to
the exposed dura. After waiting 5–10 min for the mixture to solidify, we applied 7 μl of DiI solution (20 mg/
ml in PBS with 10% DMSO, Invitrogen) or FG (2% in
0.9% saline, Fluorochrome) onto the exposed dura. Subsequently, the dura was covered with a sterile polypropylene cap that was secured over the ring using the
dental cement/superglue mix. The skin incision was
closed using stainless steel wound clips. After recovery
from anesthesia, the mice were housed individually in
the animal facility for five (for FG labeling) or ten days
(for DiI labeling) to allow the transport of the tracer to
the somata in the TG.
To label the TG neurons innervating the facial skin,
we shaved the skin at the periorbital region (between the
two eyes) and injected 7 μl of DiI or FG solution intradermally. The needle was held nearly parallel to the skin
and inserted ~1 mm into the skin. The injection was
performed slowly over a period of ~1 minute. In some
TRPM8EGFPf/+ mice, we injected 7 μl DiI intradermally
into the skin over the whisker pad. After the injection,
the mice were housed in the animal facility for five (for
FG labeling) or ten days (for DiI labeling) to allow for
transport of the tracer to the somata in the TG.
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To label both the dural and skin afferent neurons in
the same mouse, we first applied 7 μl of DiI onto the
dura and then injected 7 μl FG solution intradermally
into the periorbital skin five days after the craniectomy.
The mice were housed individually in the animal facility
for an additional five days before being euthanized.
Tissue preparation and immunohistochemistry (IHC)

The mice were euthanized by barbiturate overdose
(200 mg/kg, i.p.) and were transcardially perfused with
0.1 M phosphate-buffered saline (PBS) followed by 4%
formaldehyde in 0.1 M phosphate buffer, pH 7.4 (PB) for
fixation. The TG tissues were removed, post-fixed for
two hours, and then protected overnight in 30% sucrose
in 0.1 M PB. The ganglia were sectioned at 20 μm using
a cryostat, mounted on Superfrost Plus glass slides and
stored at −20 °C. One in every three sections (cut approximately every 60 μm) was processed for each IHC
experiment.
For IHC of the FG-labeled TG, the sections were dried
at room temperature (RT), washed three times in
0.01 M PBS and incubated in blocking buffer (0.01 M
PBS with 10% normal goat serum (NGS) and 0.3% Triton X-100) for 1 hr at RT. The sections were then incubated overnight with primary antibodies that were
diluted in blocking buffer at 4 °C. Following 3–5 10-min
washes in 0.01 M PBS containing 1% NGS and 0.3% triton and blocking for 1 hr, the sections were incubated
with the secondary antibodies in blocking buffer at RT
for 1 hour, and then washed three times in 0.01 M PBS.
The sections were cover-slipped using Fluoromount-G
Slide Mounting Medium (Electron Microscopy),
sealed with nail polish, and stored at 4 °C. For IHC of
the DiI-labeled TG, the concentration of Triton X-100
in all solutions was reduced to 0.03% to preserve the
DiI signal [38].
The primary antibodies against CGRP (Millipore) and
TRPV1 (Neuromics) were used at 1:1000 dilution. Two
antibodies against distinct extracellular domains of
TRPA1 were combined and used at 1:50 dilution as
described previously [51]. The Alexa Fluor 568- and
488-conjugated goat anti-rabbit secondary antibodies
(Invitrogen) were used at 1:1000 dilution. To measure
IB4 affinity, the sections were incubated with 2 μg/ml
Alexa Fluor 594-conjugated IB4 in blocking buffer at 4 °C
overnight.
Image acquisition and data analysis

Images of the entire TG section were captured using an
Olympus NanoZoomer Whole-Slide Imaging System at
the Alafi neuroimaging core facility at Washington University Medical School. High-power images of the TG
sections were examined and captured through a 20x objective on a Nikon TE2000S inverted epifluorescence
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microscope equipped with a CoolSnapHQ2 camera
(Photometrics). Cross-sectional somatic area was measured using SimplePCI software (Hamamatsu). Figures
were prepared using Origin 8.1 (OriginLab). The individual images were adjusted for contrast and brightness. No
other manipulations were made to the images.
Statistical analysis

All summary data are reported as the mean ± standard
error of the mean (SEM). Statistical tests were performed using Statistica10 software (StatSoft). Differences
with p < 0.05 were considered to be statistically significant. A two-tailed Student’s t-test or one-way analysis of
variance (ANOVA) with post hoc Bonferroni test was
used as the parametric statistical test where appropriate.
The non-parametric Mann–Whitney U test or the
Kruskal-Wallis ANOVA with Dunn’s post hoc test was
used where appropriate to analyze the differences in the
soma size distribution.
Nearest-neighbor measurement

The nearest-neighbor measurement was used to determine whether cells in a given TG population (e.g., dural
afferent neurons) were distributed randomly or were
clustered together [54]. Briefly, the distance between two
cells (r) was measured from the center of the cell in
question to the center of its corresponding nearest
neighbor, and the mean r value was computed using the
following equation: rA ¼ Σr
N , with N being the total
number of cells in question. The mean r value for a random distribution of cells was calculated using the following equation: rE ¼ 2p1 ﬃﬃρ , with ρ being the density of the
cell population of interest. The ratio R ¼ rA
rE of the
observed mean distance to the expected mean distance
provides a measure of the degree to which the distribution pattern of the observed population deviates from
random expectation. R can range in value from 0 (for a
distribution with maximum aggregation) to 2.1491 (for a
perfectly uniform distribution). An R value of 1 corresponds to a random distribution of the cell population.
The significance of the departure from random expectation was tested by the standard variate of the normal
curve using the following equation: c ¼ rErA
σrE , where σrE
is the standard error of rE. The c values 1.96 and 2.58
represent the 0.05 and the 0.01 levels of significance, respectively, for a two-tailed test.
We used a modified nearest-neighbor measurement to
assess the spatial association between two discrete populations of TG neurons (for example, between dural afferent neurons and TRPM8-expressing neurons) [55].
Briefly, the value of rA was obtained by averaging the
distances between a given cell in one population and its
nearest neighbor in the other population (i.e., the
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nearest-neighbor distance). The mean r value for
complete spatial independence between cells in the two
populations was calculated using the following equation:
n1ﬃﬃﬃﬃ
n2ﬃﬃﬃﬃ
rE ¼ p
þ p
, with n1 and n2 being the relative
2

ρ2

2

ρ1

proportions of the two cell populations (n1 + n2 =1), and
ρ1 and ρ2 being the densities of the two respective cell
populations. The ratio R ¼ rA
rE provides a measure of the
spatial association between two populations of cells, with
R = 1 indicating a lack of association (i.e., spatial independence). An R value less than or greater than 1 corresponds to a spatial association between two cell
populations that is more clustered than random (i.e., aggregation) or more regular than random (i.e., avoidance),
respectively. The significance of the departure from the
expected spatial independence was tested by the standard variate of the normal curve as follows: c ¼ rErA
σrE ,
where σrE is the standard error of rE. The c values 1.96
and 2.58 represent the 0.05 and the 0.01 levels of significance, respectively, for a two-tailed test.
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